Navigation Links
Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
Date:11/1/2007

rt from GlaxoSmithKline for the I Heart Flu Shots(TM) initiative.

About the Survey

This study was conducted online within the United States on behalf of Mended Hearts between September 21 and September 25, 2007 among 2,199 U.S. adults ages 18+, of whom 876 have been diagnosed with heart disease (high cholesterol, high blood pressure or hypertension, heart attack, heart failure and/or stroke) by a healthcare professional.

Results were weighted as needed for age, sex, race/ethnicity, education, region and household income. Propensity score weighting was also used to adjust for respondents' propensity to be online.

All sample surveys and polls, whether or not they use probability sampling, are subject to multiple sources of error which are most often not possible to quantify or estimate, including sampling error, coverage error, error associated with nonresponse, error associated with question wording and response options, and post-survey weighting and adjustments. Therefore, Harris Interactive avoids the words "margin of error" as they are misleading. All that can be calculated are different possible sampling errors with different probabilities for pure, unweighted, random samples with 100% response rates. These are only theoretical because no published polls come close to this ideal.

Respondents for this survey were selected from among those who have agreed to participate in Harris Interactive surveys. The data have been weighted to reflect the composition of the U.S. adult population. Because the sample is based on those who agreed to be invited to participate in the Harris Interactive online research panel, no estimates of theoretical sampling error can be calculated.

Contact: Sheryl Trager

212.798.9520


'/>"/>
SOURCE Mended Hearts
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
2. Data on Telavancin and Micafungin Hold Promise of New Therapeutic Options in Fight Against Serious Infectious Disease
3. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
4. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
5. Nationwide MRSA Prevalence Study to Demonstrate Full Scope of Superbug Threat Facing U.S. Healthcare Facilities and Patients
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
8. Antidepressant Use May Boost Fracture Risk, From Harvard Womens Health Watch
9. FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations, FDA Regulations
10. New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory Properties and Increased Health Benefits
11. Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Multiple Sclerosis Drugs Market 2014-2018" report to ... chronic, inflammatory medical condition that results in demyelination, axonal ... of an abnormal response by the immune system, which ... is a potentially debilitating disease in which the damage ...
(Date:8/29/2014)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... Officer, will present at the CL King 12 th ... 9, 2014 at 12:30 p.m. ET. The conference will ... New York City . ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, 2014 /PR ... ("DelMar" "the Company") today announced the filing of June ... changed its fiscal year end to June 30th in ... stock on a national securities exchange in the timeliest ... with the United States Securities Exchange Commission can be ...
Breaking Medicine Technology:Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... April 14, 2011 Oxford Finance Corporation (Oxford), a ... a $2 million equipment loan with Synta Pharmaceuticals Corp. ... compounds for use in Synta,s ongoing clinical trials in ... "Synta Pharmaceuticals has a diverse drug pipeline, including ...
... (NYSE: BT ) shared its vision of ... cloud computing strategies to pharma research at the Bio-IT ... This vision reflects BT,s strong capabilities and increasing specialization ... world,s leading pharmaceutical companies rely on BT to support ...
Cached Medicine Technology:Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp. 2BT Pushes for R&D Innovation at Bio-IT World Conference 2BT Pushes for R&D Innovation at Bio-IT World Conference 3
(Date:8/29/2014)... yesterday by the Mental Health Commission of Canada ... and education that police personnel receive. , "People ... Canada,s police community, and today,s report builds on ... people with mental illnesses," says Queen,s adjunct professor ... in the area of police psychology. "This is ...
(Date:8/29/2014)... New York, New York (PRWEB) August 29, 2014 ... died from cardiac arrest following a series of dialysis ... that alleges her death was the result of ... Liebhard LLP reports. The family’s lawsuit, which was file ... 2014, claims that the use of the products resulted ...
(Date:8/29/2014)... A team of scientists from the University of Colorado ... a process to expand production of stem cells used ... that extend beyond cancer, including treatments for inborn immunodeficiency ... article published Aug. 29 in PLOS ONE ... Regenerative Medicine and Stem Cell Biology and Taiga Biotechnologies, ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 ... poised to begin accepting applications next month for ... are transitioning into accepting marijuana as a legalized ... and dispensaries will be permitted to operate in ... communities will be best suited to handle legal ...
(Date:8/29/2014)... 2014 LiveOps, Inc., the global leader ... announced that LiveOps has been selected as a call ... of Strength Telethon for the third year in a ... awareness to support MDA’s mission to help children and ... fatal muscle disease. This year’s program includes performances by ...
Breaking Medicine News(10 mins):Health News:Report advocates improved police training 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4
... , , SAN FRANCISCO, Sept. 22 ... will be a key driver of economic growth in the state over ... almost 1 million workers with a collective earning power of more than ... on whether California,s education system will be able to provide enough health ...
... Finding explains why obese children have higher relapse rates, ... Leukemia cells can hide in fat tissue to evade ... are more likely to develop chemotherapy resistance and have ... found that obese children with leukemia are 50 percent ...
... take into account side effects, researchers say , TUESDAY, ... advanced prostate cancer can increase the risk of heart ... be safer than others, new research has found. , ... advanced prostate cancer or prostate cancer that had spread ...
... Role of Innovation in Global Public Health , , ... Galien USA, the equivalent to the Nobel Prize for pharmaceutical research and ... research can improve health care across the U.S. and around the world. ... M.D., founder of Biogen and a member of the Prix Galien USA ...
... 22 The Neuropathy Association has announced two awardees ... , Every year, The Neuropathy Association--the leading ... neuropathies--awards two scientific research grants, each for $80,000 over ... This year,s grant recipients--Dennis Paul, Ph.D. and co-principal investigator, ...
... , Surgeons Urge Prompt Treatment for Growth Plate ... and outdoors, youth athletes stay active year-round in competitive sports, and for many ... American College of Foot and Ankle Surgeons advises that when a child complains ... warning sign of a serious foot problem. , , ...
Cached Medicine News:Health News:Report Finds Significant Job Opportunities for Californians in Allied Health; Questions State's Education Capacity To Train Workers 2Health News:Report Finds Significant Job Opportunities for Californians in Allied Health; Questions State's Education Capacity To Train Workers 3Health News:Leukemia Cells May Hide in Fat Tissue 2Health News:Hormone Therapy for Prostate Cancer Raises Heart Risks 2Health News:Prix Galien USA to Launch a Health Care Dialogue Among World-Leading Innovators in Science, Economics and Biotech 2Health News:Neuropathy Association Research Grants Advance the Understanding of Diabetic Neuropathy and Autoimmune Neuropathies 2Health News:Heel Pain in Youth Athletes: A Warning Sign 2
Futuremeds Astotherm Plus Blood and Fluid Warmers meet American Blood Bank and ECRI standards., ,Astotherm is a durable warmer you can rely on for many years....
... anesthesia solution for the MRI environment , ... ,The Narkomed MRI-2 is the only ... monitor, designed and engineered to perform, without distance ... environments of up to 3.0 Tesla. This feature ...
... Narkomed GS provides high quality ventilation ... The proven technologies of the AV2+ ... the Narkomed GS user-friendly and intuitive. ... quality Narkomed GS is the perfect ...
... facilities where space is a premium Fabius ... delivery technologies with an ergonomic and compact ... of the Draeger Infinity patient monitoring range ... environment that is a sound investment into ...
Medicine Products: